BRAF and metastatic colorectal cancer: Loupakis Loupakis F F Cremolini Cremolini C C Salvatore Salvatore L L Folfoxiri plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer Folfoxiri plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer Eur J Cancer Eur J Cancer 2014 2014 50 50 57 57 63 63 10.1016/j.ejca.2013.08.024 10.1016/j.ejca.2013.08.024 supplied-pmid 24138831?